Cargando…
SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53
Bladder cancer (BCa) is one of the most common malignancies worldwide. However, the lack of accurate and effective targeted drugs has become a major problem in current clinical treatment of BCa. Studies have demonstrated that squalene epoxidase (SQLE), as a key rate-limiting enzyme in cholesterol bi...
Autores principales: | Zou, Fan, Chen, Wu, Song, Tianbao, Xing, Ji, Zhang, Yunlong, Chen, Kang, Hu, Weimin, Li, Linzhi, Ning, Jinzhuo, Li, Chenglong, Yu, Weimin, Cheng, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540347/ https://www.ncbi.nlm.nih.gov/pubmed/37770925 http://dx.doi.org/10.1186/s12935-023-02997-5 |
Ejemplares similares
-
Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages
por: Hu, Weimin, et al.
Publicado: (2023) -
MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer
por: Li, Linzhi, et al.
Publicado: (2023) -
Corrigendum to “Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages” [Heliyon 9(3) (March 2023) e14272]
por: Hu, Weimin, et al.
Publicado: (2023) -
Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment
por: Song, Tianbao, et al.
Publicado: (2022) -
The interaction between polyphyllin I and SQLE protein induces hepatotoxicity through SREBP-2/HMGCR/SQLE/LSS pathway
por: Li, Zhiqi, et al.
Publicado: (2023)